In addition, pharmacological inhibitionof CCL2 was able to reduce inflammation and improve podocyte function in diabeticnephropathy 19, as well as recover kidneyfunction in patients with diabetes mellitus who experienced albuminuria20,21. The gene discussed is CCL2; the disease is diabetes mellitus.